Dr Rickie Patani
University position
Wellcome Trust Intermediate Fellow, Anne Rowling Fellow
Departments
Department of Clinical Neurosciences
Institutes
The Anne McLaren Laboratory for Regenerative Medicine
Home page
Research Themes
Interests
The focus of my research is neural lineage restriction from human pluripotent stem cells and the subsequent regional fate specification of derived neural precursors. One key area of study is to investigate temporal responsiveness of human neural precursors to morphogenetic cues and, by using insights gained from this work, to generate both neurons and glia in chemically defined conditions. The generation of clinically relevant human neural cell types provides an unprecedented experimental opportunity to both study human neurodevelopmental processes and to model neurodegenerative disease in-vitro.
Research Focus
Keywordsstem cells neurodegenerative brain disorders |
Clinical conditionsMotor neurone disease Multiple sclerosis |
Equipment
Cell culture
Immunohistochemistry
Collaborators
No collaborators listed
Key publications
Patani R, Lewis PA, Trabzuni D, Puddifoot CA, Wyllie DJ, Walker R, Smith C, Hardingham GE, Weale M, Hardy J, Chandran S, Ryten M (2012), “Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole genome gene expression and splicing analysis.” J Neurochem Details
Patani R, Sibley CR, Chandran S, Ule J (2012), “Using human pluripotent stem cells to study post-transcriptional mechanisms of neurodegenerative diseases.” Brain Res Details
Patani R, Hollins AJ, Wishart TM, Puddifoot CA, Alvarez S, de Lera AR, Wyllie DJ, Compston DA, Pedersen RA, Gillingwater TH, Hardingham GE, Allen ND, Chandran S (2011), “Retinoid-independent motor neurogenesis from human embryonic stem cells reveals a medial columnar ground state.” Nat Commun 2:214 Details
Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Zupunski V, Patani R, Chandran S, Rot G, Zupan B, Shaw CE, Ule J (2011), “Characterizing the RNA targets and position-dependent splicing regulation by TDP-43.” Nat Neurosci Details
Hardingham GE, Patani R, Baxter P, Wyllie DJ, Chandran S (2010), “Human Embryonic Stem Cell-Derived Neurons as a Tool for Studying Neuroprotection and Neurodegeneration.” Mol Neurobiol Details
Patani R, Compston A, Puddifoot CA, Wyllie DJ, Hardingham GE, Allen ND, Chandran S (2009), “Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.” PLoS One 4(10):e7327 Details
Patani R, Balaratnam M, Vora A, Reynolds R (2007), “Remyelination can be extensive in multiple sclerosis despite a long disease course.” Neuropathol Appl Neurobiol 33(3):277-87 Details
Publications
2013
Athappily C, Patani R, Chawda S, Rosser E, de Silva R (2013), “TS or not TS?” Pract Neurol Details
Patani R, Muhammed N, Chaudhuri A (2013), “Flexor hallucis brevis spasm.” Muscle Nerve 47(6):939 Details
Reimer MM, Norris A, Ohnmacht J, Patani R, Zhong Z, Dias TB, Kuscha V, Scott AL, Chen YC, Rozov S, Frazer SL, Wyatt C, Higashijima SI, Patton EE, Panula P, Chandran S, Becker T, Becker CG (2013), “Dopamine from the Brain Promotes Spinal Motor Neuron Generation during Development and Adult Regeneration.” Dev Cell Details
Shribman S, Patani R, Deeb J, Chaudhuri A (2013), “Voltage-gated potassium channelopathy: an expanding spectrum of clinical phenotypes.” BMJ Case Rep 2013 Details
2012
Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, Du MQ, Luan SL, Altmann DR, Thompson AJ, Compston A, Scott MA, Miller DH, Chandran S (2012), “Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study.” Lancet Neurol Details
Patani R, Chandran S (2012), “Experimental and therapeutic opportunities for stem cells in multiple sclerosis.” Int J Mol Sci 13(11):14470-91 Details
Thomson SR, Wishart TM, Patani R, Chandran S, Gillingwater TH (2012), “Using induced pluripotent stem cells (iPSC) to model human neuromuscular connectivity: promise or reality?” J Anat 220(2):122-130 Details
2011
Bell KF, Al-Mubarak B, Fowler JH, Baxter PS, Gupta K, Tsujita T, Chowdhry S, Patani R, Chandran S, Horsburgh K, Hayes JD, Hardingham GE (2011), “Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning.” Proc Natl Acad Sci U S A 108(1):E1-2; author reply E3-4 Details
Connick P, Kolappan M, Patani R, Scott MA, Crawley C, He XL, Richardson K, Barber K, Webber DJ, Wheeler-Kingshott CA, Tozer DJ, Samson RS, Thomas DL, Du MQ, Luan SL, Michell AW, Altmann DR, Thompson AJ, Miller DH, Compston A, Chandran S (2011), “The Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) Trial protocol and baseline cohort characteristics: an open-label pre-test : post-test study with blinded outcome assessments.” Trials 12(1):62 Details
Connick P, Patani R, Chandran S (2011), “Stem cells as a resource for regenerative neurology.” Pract Neurol 11(1):29-36 Details
Gupta K, Patani R, Baxter P, Serio A, Story D, Tsujita T, Hayes JD, Pedersen RA, Hardingham GE, Chandran S (2011), “Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms.” Cell Death Differ Details
Tan CL, Kwok JC, Patani R, Ffrench-Constant C, Chandran S, Fawcett JW (2011), “Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling.” J Neurosci 31(17):6289-95 Details
2010
Anderson JM, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S (2010), “Abnormal tau phosphorylation in primary progressive multiple sclerosis.” Acta Neuropathol 119(5):591-600 Details
Iovino M, Patani R, Watts C, Chandran S, Spillantini MG (2010), “Human stem cell-derived neurons: a system to study human tau function and dysfunction.” PLoS One 5(11):e13947 Details
2009
Anderson JM, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S (2009), “Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.” Acta Neuropathol 117(5):583-9 Details
2008
Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, Franklin RJ, Giovannoni G, Compston DA, Baker D, Spillantini MG, Chandran S (2008), “Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.” Brain 131(Pt 7):1736-48 Details


